Current clinical management of constitutional delay of growth and puberty

被引:8
|
作者
Gaudino, Rossella [1 ]
De Filippo, Gianpaolo [2 ,3 ]
Bozzola, Elena [4 ]
Gasparri, Manuela [5 ]
Bozzola, Mauro [6 ]
Villani, Alberto [4 ]
Radetti, Giorgio [7 ]
机构
[1] Univ Verona, Dept Surg Sci Dent Gynecol & Pediat, Pediat Div, Verona, Italy
[2] Hop Robert Debre, AP HP, Serv Endocrinol & Diabetol Pediat, Paris, France
[3] French Clin Res Grp Adolescent Med & Hlth, Paris, France
[4] IRCCS Bambino Gesu Children Hosp, Pediat Unit, Rome, Italy
[5] San Paolo Hosp, Dept Pediat, Milan, Italy
[6] Univ Pavia, Pavia, Italy
[7] Prov Autonoma Bolzano, Bolzano, Italy
关键词
Puberty; Delayed puberty; Bone age; Growth; Constitutional delay of growth and puberty; Hypogonadotropic hypogonadism; PATTERN;
D O I
10.1186/s13052-022-01242-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Constitutional delay of growth and puberty (CDGP) is classified as the most frequent cause of delayed puberty (DP). Finding out the etiology of DP during first evaluation may be a challenge. In details, pediatricians often cannot differentiate CDGP from permanent hypogonadotropic hypogonadism (PHH), with definitive diagnosis of PHH awaiting lack of puberty by age 18 yr. Neverthless, the ability in providing a precise and tempestive diagnosis has important clinical consequences. Main text: A growth failure in adolescents with CDGP may occur until the onset of puberty; after that the growth rate increases with rapidity. Bone age is typically delayed. CDGP is generally a diagnosis of exclusion. Nevertheless, other causes of DP must be evaluated. A family history including timing of puberty in the mother and in the father as well as physical examination may givee information on the cause of DP. Patients with transient delay in hypothalamicpituitary- gonadal axis maturation due to associated conditions, such as celiac disease, inflammatory bowel diseases, kidney insufficiency and anorexia nervosa, may experience a functional hypogonadotropic hypogonadism. PHH revealing testosterone or estradiol low serum values and reduced FSH and LH levels may be connected to abnormalities in the central nervous system. So, magnetic resonance imaging is required in order to exclude either morphological alterations or neoplasia. If the adolescent with CDGP meets psychological difficulties, treatment is recommended. Conclusion: Even if CDGP is considered a variant of normal growth rather than a disease, short stature and retarded sexual development may led to psychological problems, sometimes associated to a poor academic performance. A prompt and precise diagnosis has an important clinical outcome. Aim of this mini-review is throwing light on management of patients with CDGP, emphasizing the adolescent diagnosis and trying to answer all questions from paediatricians.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Anti-Mullerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone
    Kohva, E.
    Varimo, T.
    Huopio, H.
    Tenhola, S.
    Voutilainen, R.
    Toppari, J.
    Miettinen, P. J.
    Vaaralahti, K.
    Viinamaki, J.
    Backman, J. T.
    Hero, M.
    Raivio, T.
    HUMAN REPRODUCTION, 2020, 35 (02) : 257 - 264
  • [42] Androgen therapy in constitutional delay of growth
    Lampit, M
    Hochberg, Z
    HORMONE RESEARCH, 2003, 59 (06) : 270 - 275
  • [43] CONSTITUTIONAL DELAY OF GROWTH - EXPECTED VERSUS FINAL ADULT HEIGHT
    LAFRANCHI, S
    HANNA, CE
    MANDEL, SH
    PEDIATRICS, 1991, 87 (01) : 82 - 87
  • [44] Inhibin B, AMH, but not INSL3, IGF1 or DHEAS support differentiation between constitutional delay of growth and puberty and hypogonadotropic hypogonadism
    Rohayem, J.
    Nieschlag, E.
    Kliesch, S.
    Zitzmann, M.
    ANDROLOGY, 2015, 3 (05) : 882 - 887
  • [45] Contributions of Common Genetic Variants to Constitutional Delay of Puberty and Idiopathic Hypogonadotropic Hypogonadism
    Lippincott, Margaret F.
    Schafer, Evan C.
    Hindman, Anna A.
    He, Wen
    Brauner, Raja
    Delaney, Angela
    Grinspon, Romina
    Hall, Janet E.
    Hirschhorn, Joel N.
    McElreavey, Kenneth
    Palmert, Mark R.
    Rey, Rodolfo
    Seminara, Stephanie B.
    Salem, Rany M.
    Chan, Yee-Ming
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (01): : e61 - e67
  • [46] A Double-Blind, Placebo-Controlled Comparison of Letrozole to Oxandrolone Effects upon Growth and Puberty of Children with Constitutional Delay of Puberty and Idiopathic Short Stature
    Salehpour, Shadab
    Alipour, Parvin
    Razzaghy-Azar, Maryam
    Ardeshirpour, Laleh
    Shamshiri, Alireza
    Monfared, Mahtab Farahmand
    Gharib, Atoosa
    HORMONE RESEARCH IN PAEDIATRICS, 2010, 74 (06): : 428 - 435
  • [47] Progressive reduction of relative height in childhood predicts adult stature below target height in boys with constitutional delay of growth and puberty
    Wehkalampi, Karoliina
    Vangonen, Katarina
    Laine, Tiina
    Dunkel, Leo
    HORMONE RESEARCH, 2007, 68 (02) : 99 - 104
  • [48] OSTEOCALCIN AND 1,25-DIHYDROXYVITAMIN-D VALUES IN CHILDREN WITH CONSTITUTIONAL DELAY OF GROWTH AND PUBERTY WITH NONCLASSICAL GH-DEFICIENCY
    SAGGESE, G
    BARONCELLI, GI
    BERTELLONI, S
    CESARETTI, G
    CINQUANTA, L
    CARLOTTI, C
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1991, 17 (02): : 209 - 212
  • [49] Early-life stress and current stress predict BMI and height growth trajectories in puberty
    Zhong, Danruo
    Reid, Brie M.
    Donzella, Bonny
    Miller, Bradley S.
    Gunnar, Megan R.
    DEVELOPMENTAL PSYCHOBIOLOGY, 2022, 64 (08)
  • [50] Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review
    Mauras, Nelly
    Ross, Judith
    Mericq, Veronica
    ENDOCRINE REVIEWS, 2023, 44 (01) : 1 - 13